MSI2 and lung cancer: Similarly, upregulation of MSI2 is an indicator of increased metastatic potential in lung cancer (Kudinov et al. 2016) and hepatocellular carcinoma (Kudinov et al. 2016), and is proposed to stimulate EMT through stimulation of canonical Wnt signaling (Wang et al. 2015).